• Home
  • MJNews @PRNewswire
  • MJChannelOne
  • MJBA.net
  • MJHeadlineNews
  • Subscribe
  • Advertise
  • MJBA PR

MJNews Network

"The Voice of Legal Cannabis Since 2013"

  • Home
  • Business
  • MJNews by PRNewswire
  • Legal
  • Events
  • BlPOC in Cannabis
  • MJBAPR
  • MJAdnet
You are here: Home / Archives for CBD and Alzheimer’s Disease

Cannabinoids In Cannabis Help Treat Alzheimer’s Disease

September 21, 2020 by MJ News Network Leave a Comment

In honor of World Alzheimer’s Month, we’ve asked educator/author Curt Robbins to provide an overview of how the cannabinoids in cannabis can be helpful in treating this mental illness.

By Curt Robbins

Discovered in 1906 by Dr. Alois (Aloysius) Alzheimer, a German psychiatrist and neuropathologist, Alzheimer’s disease is the sixth leading cause of death in the United States. Alzheimer stumbled upon the ailment when performing an autopsy on the brain of a woman who died of a then-unknown mental illness.

Surprisingly, Alzheimer’s disease begins damaging the brain up to a decade prior to the onset of any form of short-term memory loss—the stereotypical first discernible symptom of the disease that leads to a positive diagnosis.

The cannabinoids in cannabis help treat Alzheimer’s disease via a mechanism involving the removal of the excess plaques and tau tangles from the brain. Research indicates that some cannabinoids may transport these damaging plaques through the blood-brain barrier and out of the brain. Consumption of cannabinoids to remove plaque from the brain may result in improvement, but significant progress is strongly dependent on the progress of the disease with respect to how large a portion of the brain has suffered damage.

Formal research, anecdotal evidence, and personal testimonials have revealed that treatment with cannabinoids may slow or even halt the progression of Alzheimer’s disease. In some cases, memory function may be partially or mostly restored.

Read the entire article here:

Copyright © 2020 by Curt Robbins. All Rights Reserved.

Filed Under: Homepage, Medical Tagged With: cannabinoids, cannabinoids in cannabis, Cannabinoids In Cannabis And Alzheimer's Disease, cannabis and Alzheimer's, CBD and Alzheimer's Disease, Curt Robbins, dementia, Dr. Alois Alzheimer, medical benefits of cannabis, mjnews, mjnewsnetwork.com

Today Is World Alzheimer’s Day

September 21, 2020 by MJ News Network 1 Comment

September 21st is World Alzheimer’s Day, a date recognized by the Alzheimer’s Society globally. This important date marks the need to defend and raise awareness in society about the importance of prevention, early diagnosis and care offered, as well as support and assistance to family members and caregivers of people living with Alzheimer’s disease.

 

According to the WHO, it is estimated that there are around 50 million people with dementia in the world, and this number should triple in the next 30 years. Alzheimer’s disease is the most common form of dementia and can contribute to 60-70% of cases.

Dementia is one of the main causes of disability and dependence among elderly people around the world. Dementia has a physical, psychological, social and economic impact not only on people with dementia, but also on their caregivers, families and society in general.

 

Research on cannabis and Alzheimer’s continues to develop and may present an additional option for treatment

 

Different scientific studies highlight the use of medicinal cannabis for the treatment of Alzheimer’s symptoms. The main properties of cannabinoids for the treatment of symptoms would be: anti-inflammatory, neuroprotective and antioxidant.

 

Global medical affairs director of Spectrum Therapeutics, Dr. Wellington Briques, highlights some of these studies and their results below and is available for interviews.

 

  1. The therapeutic potential of the endocannabinoid system for Alzheimer’s disease

 

Based on the complex pathology of Alzheimer’s disease, a preventive and multimodal drug approach that targets a combination of pathological symptoms of Alzheimer’s disease seems ideal. It is important to note that cannabinoids have anti-inflammatory, neuroprotective and antioxidant properties and have immunosuppressive effects. 

 

  1. In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s Disease

 

Studies have demonstrated the ability of the CBD to reduce reactive gliosis and neuroinflammatory response, as well as to promote neurogenesis. It is important to note that the CBD also reverses and prevents the development of cognitive deficits in AD rodent models. Interestingly, the combined therapies of CBD and Δ9-tetrahydrocannabinol (THC), show that CBD can antagonise the psychoactive effects associated with THC and possibly mediate greater therapeutic benefits than any of the phytochanabinoids alone. The studies provide “proof of principle” that CBD and possibly CBD-THC combinations are valid candidates for new AD therapies. Further research should address the long-term potential of CBD and evaluate the mechanisms involved in the therapeutic effects described.

 

  1. Using CBD (Cannabidiol) to Treat the Symptoms of Alzheimer’s & Other Dementias
The brain cells of Alzheimer’s patients often show a path of rapid decline and destruction. The potential to stimulate brain tissue has recently been discovered as a potential benefit of CBD. In clinical trials, the BDC has demonstrated the ability to reverse and even prevent the development of the negative impact of Alzheimer’s disease. A 2011 study by Australian researchers Tim Karl and Carl Group revealed that CBD promotes the growth and development of brain cells, reducing the decline in memory and other brain functions.

Filed Under: Events, Homepage Tagged With: Alzheimer's Society, cannabis and Alzheimer's, CBD and Alzheimer's Disease, dementia, mmj, WHO, World Alzheimer's Day

Connect with Us!

  • Email
  • Facebook
  • Instagram
  • LinkedIn
  • Pinterest
  • RSS
  • Tumblr
  • Twitter
  • Vimeo
  • YouTube

Top Stories

Ohio Board of Pharmacy Publishes Updated Patient & Caregiver Numbers for June 2022

OHIO:  The State of Ohio Board of Pharmacy published updated patient & caregiver numbers for June 2022.  These numbers include: 526,255 Recommendations 285,621 Registered patients 18,058 Patients with Veteran Status 19,536 Patients with Indigent Status 1,122 Patients with a Terminal Diagnosis 148,950 Patients with both an active registration and an active recommendation 265,520 Unique patients Read the full article…

Michigan’s Cannabis Regulatory Agency Recognizes 21 Qualifiers in New Social Equity All-Star Program

MICHIGAN: The Cannabis Regulatory Agency (CRA) announced this week the first approved gold qualifier through the Social Equity All-Star Program, a new initiative to encourage cannabis industry licensees to be proactive in their diversity, equity, and inclusion campaigns. In addition to the first gold qualifier, the agency also announced the first 20 bronze qualifiers in Read the full article…

OLCC Commissioners Plan to Tighten “Change of Ownership” Option

Bad actors won’t get easy off-ramp to sell their businesses OREGON:  The Oregon Liquor and Cannabis Commission (OLCC) has grown tired of “bad actors” gaming the system when they’re caught breaking the law or violating OLCC rules, so Commissioners plan to crack down on that group of licensees by limiting their ability to monetize their Read the full article…

Mammoth Labs Cannabis Golf Tournament is August 6th, 2022 in Roslyn, WA

MAMMOTH LABS CANNABIS GOLF CHAMPIONSHIP August 06, 2022 Suncadia Resort – Roslyn, Wa STREAMING MJNEWS POWERED BY PR NEWSWIRE

OLCC Task Force on Cannabis-Derived Intoxicants and Illegal Cannabis Production

  Task Force on Cannabis-Derived Intoxicants and Illegal Cannabis Production Cannabinoid Subcommittee Meeting Notice AGENDA 9:30 AM – 11:30 AM Tuesday, August 2, 2022 Location: Virtual – Microsoft Teams meeting Click here to join the meeting on Teams Or call in (audio only) 323-553-3576; Passcode: 282 099 157#   TURN ON. TUNE IN. CATCH THE Read the full article…

Michigan’s Cannabis Regulatory Agency Recognizes 21 Qualifiers in New Social Equity All-Star Program

OLCC Commissioners Plan to Tighten “Change of Ownership” Option

Mammoth Labs Cannabis Golf Tournament is August 6th, 2022 in Roslyn, WA

Tags

CA California Canada cannabis cannabis news CBD changing attitudes CO Colorado DC decriminalization dispensary District of Columbia end failed war on drugs end of failed war on drugs failed war on drugs Hemp I-502 legal cannabis legalization legal marijuana legal pot shop marijuana marijuana business medical cannabis medical marijuana mjlegal mjnews MJNews Network mjnewsnetwork.com mmj New York NORML NY OH Ohio OR Oregon politicians on pot recreational marijuana the business of cannabis the business of marijuana WA Washington WSLCB

Search By State:

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming

© Copyright 2014 MJBA Publishing · MJ News Network · All Rights Reserved ·